Medindia
Browse this site with No Ads Click Here
Medindia » Research News

Safer Method for Newborn Blood Cell Transfer

by Karishma Abhishek on May 7, 2024 at 9:55 PM
Listen to this News

Transferring blood cells to weakened newborns via their umbilical cord poses no long-term neurodevelopmental risks compared to the usual practice as per research presented at the Pediatric Academic Societies (PAS) 2024 Meeting, in Toronto ().


Umbilical cord blood contains oxygen and beneficial nutrients for newborns, experts say. Doctors may delay clamping a newborn's umbilical cord to pass nutrients through their cord if they have poor breathing or a low heart rate immediately after birth.

Did You Know?
The global umbilical cord blood banking market was valued at over $8.5 billion in 2020 and is projected to grow significantly in the coming years. #newborns #bloodcells #umbilicalcord’

A study found that umbilical cord milking (UCM), an alternative method of transferring cord blood where a doctor squeezes the umbilical cord toward the infant before clamping, does not cause long-term harm.

Umbilical Cord Blood Transfer Examined

Researchers assessed 971 children's communication, motor skills, problem-solving, and social skills across 10 U.S. medical centers.

Study authors found that children who received UCM at birth were no more likely to have neurological challenges two years after the procedure compared to those who received early cord clamping.

"The short- and long-term benefits point to UCM as a safe alternative for ensuring weakened newborns can live a full, healthy life," said Anup Katheria, MD, physician at Sharp Mary Birch Hospital for Women & Newborns and presenting author.

"UCM is a no-cost option for obstetricians to preserve the health and wellbeing of children."

Study authors say raising awareness of UCM as a safe option for supporting weakened newborns is important to promoting equity among resource-limited settings.

Reference:
  1. LB02 Long Term Outcomes for The Milking In Non-Vigorous Infants (MINVI) Trial - (https:www.ajog.org/article/S0002-9378(23)02177-4/fulltext)

Source: Eurekalert

View Non AMP Site | Back to top ↑